previous year. This was mainly due to the decreased in export sales to the Middle East and African zone as these zones are facing economic problems. Therefore, the Company delayed sales transaction to
Allowance of doubtful accounts source of Transaction Action to be taken New Decade Co.,Ltd. Mrs.Sutasanee Karnasuta is the authorized director of New Decade Co., Ltd.. Mrs.Sutheera Phuttharee is the
. Indo-Rama Synthetics Tbk. ซึง่เป็นบคุคลท่ีเก่ียวโยงกนั เหตุผลของการเข้าท ารายการ (Rationale of the transaction) ตามสญัญาคอลออปชัน่ (Call Option Agreement) ระหวา่ง INBV และ PTIRS ฉบบัลงวนัท่ี 30 พฤศจิกายน
, consolidated financial statement has net loss of Baht 41 million and net profit of Baht 39 million, respectively. This was resulted from non-core business transaction of the Company, which is accounted for Baht
reversal of such transaction of Baht 0.7 million in Q2/2020. The interest expenses in Q2/2020 was Baht 1.9 million, or 44.19% decreased from Baht 3.3 million of Q2/2019. This was due to the downward trend of
, the Company would like to report the progress of this transaction that during Q4/2019 Wuttisak Clinic sent the notification letter to TPN requesting the debt payment. In addition, Wuttisak Clinic
Statement year ended March 31, 2020 Return on Assets and Return on Equity of 1Q’20 deteriorated yoy. because of high profit of base year which was driven by both the hospital business and extra transaction of
of the previous year, mostly from revenue from Trading (Big Lot – non regular transaction) decreased Baht 852.55 million. 2. Gross profit was Baht 55.63 million which decreased Baht 53.55 million or
office agreed to execute such transaction even though the contact phone number was not the one given by the client; (3) surveillance system to prevent conflicts of interest: the system was found to be
contact the client via the phone number given by the client, and (c) the back office agreed to execute such transaction even though the contact phone number was not the one given by the client; (3